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THE IMPACT OF THE VACCINE SUPPLY CHAIN ON THE SOCIOECONOMIC 
STATUS OF REGIONS IN NIGER 
 
Brigid E. Cakouros, MPH 
University of Pittsburgh, 2012 
 
The link between low socioeconomic status and limited access to vaccines has been established 
in both developed and developing nations.  Access to vaccines can be hindered in two ways: the 
population not utilizing available services, and immunization locations not offering enough 
vaccine to supply the demand.  In the ecological framework of an immunization program, this 
point is critical to understand in order to assess the current national immunization program. 
This study aimed to understand if the way the vaccine supply chain (i.e., the ordered 
system in which vaccines travel from the manufacturer to the clinics) is currently designed could 
be reflecting socioeconomic conditions of Nigeriens through three main measures: vaccine 
availability, socioeconomic status, and vaccine coverage.  Consistently ranked one of the poorest 
nations in the world with a high burden of disease, it is vital to understand if the immunization 
program in Niger is functioning to its best ability to ensure resources are being adequately 
utilized.  Vaccine availability determined the ratio of available vaccine to the demand of the 
population to be vaccinated.  Socioeconomic status was determined by a multi-faceted measure 
that encompassed the state of poverty in Niger.  Vaccine coverage represented the percentage of 
the vaccine-eligible population that actually was vaccinated. 
Results indicate that most regions have vaccine availability much higher than the vaccine 
coverage; therefore, the supply chain is not hindering access to the vaccines by not supplying 
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adequate amounts of vaccines.  For those that presented coverage higher than availability, 
evidence demonstrates that private health providers are most likely influencing the pattern and 
accessibility of immunization sessions.  Regions did not experience lower vaccine availability 
based on socioeconomic status; in fact, although coverage rates were indeed lower in regions of 
lower socioeconomic status, these regions had the highest availability.  This study demonstrates 
the public health significance of understanding an immunization program from all levels of 
supply and demand within a country in order to make the best use of the resources available. 
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1.0  INTRODUCTION 
 
Immunization is considered one of the most cost effective ways to save lives and prevent 
disease[1].  T he Expanded Program on Immunization (EPI), developed by the World Health 
Organization in 1974, w as designed to provide access to life-saving vaccines for all children 
worldwide.  Vaccines today remain at the frontline of the battle against communicable disease in 
many low income countries and offer the more financially sound alternative of preventing, rather 
than treating, disease.  Concerns such as diarrheal disease, pneumonia, and meningitis finally 
have answers in the form of vaccines, and some of these answers are even fully funded to lower 
the economic burden of introduction.  Although these advancements in vaccinology are 
important healthcare milestones, there remains one aspect that is critical to the successful 
application of these advancements: access to vaccines.  It is estimated that one third of the 
world’s population does not have regular access to vaccines[2].   
 Access can adopt numerous definitions and be measured in multiple ways.  In the most 
basic sense, access refers to a person’s capability to obtain and properly utilize health 
services[2].   In regards to vaccines, access encompasses the ability to receive necessary 
immunizations in a timely manner.  Although there are many factors affecting vaccine access, 
there are two basic yet critical steps that must occur in order to vaccinate the population.  First, 
vaccines need to be available at clinics to supply the demand.  National vaccine supply chains 
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operate to deliver vaccines from the manufacturers down to the clinic levels, predicting the 
necessary shipment size needed to reach the clinic level based on the size of the population a 
clinic serves.  Second, the population needs to arrive to the clinic to get vaccinated.  The link 
between low socioeconomic status and vaccination uptake has been established[3, 4].  Areas of 
lower socioeconomic status tend to have lower rates of health seeking behaviors.  In the context 
of a developing nation that is assumed to be uniformly poor, health disparities still exist among 
regions of varying poverty status[5].  Niger is such a country.  Niger is ranked as one of the 
poorest countries in the world, and a majority of Niger lives in extreme poverty.  However, 
understanding regional differences in poverty in relation to vaccine availability could help better 
focus efforts to immunize more of the population. 
The aim of this study is to better understand the relationship between the vaccine 
availability (as measured by the available vaccines offered at clinics to meet the population 
demand) with vaccine coverage (as measured by the percentage of the population vaccinated) at 
the regional level in Niger.  Is the way the vaccine supply chain currently structured potentially 
exacerbating regions of lower economic status, therefore further impacting health disparities by 
affecting vaccine coverage?  This study will help stakeholders understand the relationship 
between availability and coverage in Niger, and can offer evidence to support potential changes 
to the vaccine supply system that will maximize the opportunity to vaccinate. 
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2.0  LITERATURE REVIEW 
2.1 VACCINE PREVENTABLE DISEASE 
The first step to understanding a vaccination program is to understand the burden of vaccine 
preventable disease (VPD.)  It is estimated that 17% of deaths of children under five years old is 
attributable to disease that could have been prevented by vaccination[6].  Such diseases include 
diphtheria, measles, tetanus, rotavirus, and yellow fever, to name a few.  Some diseases, such as 
maternal tetanus, polio, and measles, have specific goals of eradication. 
 The burden of such disease is different per country.  Vaccine uptake plays a large part, 
but there are other factors impacting control of these diseases.  Geography, seasonal patterns, 
overcrowding, migration, and potential genetic differences play an important role in determining 
disease control.  Some diseases are spread through respiratory infection, others through blood 
contact.  Some are transmitted from human contact and others are vector-born.  Control of each 
of these diseases in each country should adopt plans that encompass numerous factors.  For 
example, hepatitis B control varies between Southeast Asia and sub-Saharan Africa.  In 
Southeast Asia, it is usually transmitted vertically, or from an infected mother to her child during 
pregnancy or delivery.  However, in sub-Saharan Africa, hepatitis B is usually transmitted 
horizontally, or by a means other than mother-to-child or sexual contact.  O ften, this can be 
spread from child to child when one child is unknowingly infected[7]. 
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Sub-Saharan Africa accounts for a high percentage of the burden of disease attributable 
to VPD.   58% of pertussis deaths, 41% of tetanus deaths, 59% of measles deaths, and 80% of 
yellow fever deaths occur in this region of the world[8].  Estimating such numbers can be 
difficult, as countries all have different methods of disease reporting and surveillance; however, 
the pattern of high rates of these diseases remains consistent across the region.  S trong 
immunization programs have the ability to help control such disease.  Smallpox eradication is 
one of the strongest testaments to the need of strong immunization programs supplemented by 
substantial campaigns that catch “missed opportunities,” those patients that miss vaccination 
opportunities offered by a clinic.  Other efforts, such as measles and polio, are modeled after the 
success of smallpox eradication campaigns[9].  However, the strongest force against VPD lies in 
the success of a national immunization schedule guided by ways to control and prevent 
outbreaks. 
 
2.2 THE EXPANDED PROGRAM ON IMMUNIZATION 
The Expanded Program on Immunization (EPI) was established in 1974 by the World Health 
Organization with the goal of providing all children access to life saving vaccines to prevent and 
control vaccine preventable diseases.  It was modeled after the success of smallpox eradication 
campaigns[9].  The EPI originally targeted diphtheria, tetanus, pertussis, measles, polio and 
tuberculosis.  Other vaccines have since been added, including hepatitis B and Haemophilus 
influenza type b (Hib.)  Although the EPI varies by country, the eight vaccines listed above are 
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the basic requirements of most national policies.  In addition, some countries have region 
specific vaccines, such as yellow fever and Japanese encephalitis. 
Over the years, advancements in research have combined many of these vaccines, such as 
the commonly used trivalent DTP (protecting against diphtheria, tetanus, and pertussis in a 3 
dose vaccine.)  The coverage rate for three doses of DTP is also the most common measure of a 
vaccine program across the globe.  The EPI supports each country to developing its own 
vaccination delivery system according to the ongoing health conditions of that country[9].  The 
core EPI vaccines should all be administered in the first year of life.  While this can be 
expensive, UNICEF has been critical in the negotiation of acquiring vaccines at lower prices. 
The Global Immunization and Vision Strategy (GIVS) is a framework developed by the 
World Health Organization and UNICEF in order to help countries outline stronger 
immunization plans.  This ten year strategy has four main goals: to immunize more people, to 
introduce new vaccines, to integrate immunization into other health interventions, and to help 
countries be able to manage vaccine programs independently.  In addition, GIVS can help 
develop regional vaccine programs within countries in order to better supply specific areas that 
need attention[10].   
Aside from creating vaccination schedules, the intent of the EPI is also to supply cold 
chain equipment (refrigerators, freezers, cold rooms, vaccine carriers, etc.) in order to ensure the 
safety of vaccines traveling through the system.  In developing countries this was a challenge.  
Issues such as fickle power sources, unreliable road conditions, and limited storage capacity 
existed in nearly every setting in every country.  However, WHO and UNICEF developed ways 
to finance the purchase and allocation of such equipment[9].  Just as UNICEF’s purchasing 
power helped to obtain vaccines at reasonable prices, this was true with equipment. 
 6 
As the EPI continues to adapt to new technologies, emerging diseases, and shifting health 
trends, it is important to be able to make educated decisions affecting the supply chain in order to 
control health outbreaks and epidemics.  Vaccine supply chains include all of the people, 
equipment, and activities that must harmoniously work together in order to deliver vaccines from 
the producer to the patient[11].  People involved include everyone from the Ministry of Health to 
the health worker delivering vaccines; equipment encompasses cold rooms and hand-held 
vaccine carriers; activities include both delivering vaccines to locations and administering doses 
to patients.  Temperature control is a critical step to ensuring proper vaccine delivery.  
Originally, the cold chain was created to keep vaccines between the recommended temperature 
of 2-8˚C.  However, recent studies show that exposure to freezing temperatures along the supply 
chain is becoming just as much a problem as heat[12, 13]. 
Predicting adjustments to the supply chain that would be needed in situations such as 
vaccine introduction, vial size change, additional space needed, and changes in supply routes, 
among others, is challenging.  Fortunately, modeling public health dynamics through equation-
based and computational models has produced better means of analyzing such changes.  
Utilizing a computational model to evaluate changes to the vaccine supply chain can help capture 
more of the counterintuitive effects that take place or would otherwise be unaccounted for with a 
single equation-based model.  Such models are country specific and usually constructed with real 
data from the ground, so outputs are quite reliable.  Computational models of the supply chain 
can evaluate existing supply chain functions and strengthen the EPI, evaluate the impacts of 
adjustments to the supply chain before implementation, and create evidence for policy 
interventions regarding necessary supply chain refinement[14].  These computer models of the 
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vaccine supply chain, built specifically to simulate real-life complexities, grant policy makers the 
ability to determine the best way to supply an immunization program. 
 
2.3 THE SOCIAL ECOLOGICAL FRAMEWORK 
Vaccine coverage rates reflect a multitude of factors that influence why a person would chose to 
be vaccinated.  From the government deeming what vaccines are included in the national 
immunization plan and the clinic managers determining what days they will be open to parents 
accepting the vaccine, it is important to understand how each level affects the overall vaccine 
coverage in order to determine where to best intervene to increase vaccine uptake. 
The social ecological model encompasses influences from numerous levels within a 
systems theory approach.  All levels affect one another either directly it on a cyclical patter.  The 
theoretical model states that behavior is influenced at five different levels: intrapersonal, 
interpersonal, institutional, community, and public policy[15].  Characteristics at the 
intrapersonal level include (but are not limited to) knowledge, skills, self-image, personal 
history; at the interpersonal level include relationships with family, friends, and coworkers; at the 
institutional level include organizations and structures such as type of employment and 
neighborhood surroundings; at the community level include places such as community centers 
and churches, and how they work in a network; at the policy level include the regulatory policies 
and laws in place to protect the health of the population.  The four core principles of the 
ecological perspective state that there are multiple influences on health behavior, that these 
influences occur across all levels, the model is most effective when designed for a specific 
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behavior with relevant potential influences identified at each level, and that interventions 
crossing multiple levels are the most effective[15]. 
There are limited resources linking the social ecological model to an entire immunization 
program.  Research tends to focus on individual levels; however, studies rarely capture the 
interaction between multiple levels within the model[16].  Models, such as the Mosley and Chen 
framework for child survival, focus on the attributes of the caregiver, household and community 
[17].  While these influences are of major importance to immunization uptake, it offers a limited 
view of the social ecological framework. 
One study in Nigeria outlined the factors influencing acceptance and uptake of the 
Bacille Calmette-Guérin (BCG) vaccine in regards to an ecological model[3].  B CG is the 
vaccine given at birth to protect an infant against tuberculosis infection.  Nigeria’s average BCG 
coverage rate is 18.1%, while the regional coverage rates range from 6.2% to 29.6%.  
Researchers applied the five levels of influence in regards to vaccination in Nigeria as: 
• Intrapersonal: individual child characteristics (gender, place of birth, family 
order) 
• Interpersonal: parental and household factors (education, immunization 
acceptance, prenatal care) 
• Institutional: community characteristics (neighborhood dynamics and social 
norms) 
• Community: service delivery factors (location of health clinics and availability) 
• The immunization policy environment of Nigeria (national program goals) 
The goal of this study was to understand what influenced a child to be immunized and 
utilized data from in-country surveys.  As an infant does not make the decision, the strongest 
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influences were in regard to maternal knowledge about immunization, paternal approval, and 
social influence.  Vaccine supply and location of residence were strong indicators as well, 
emphasizing the need to intervene in immunization programs at multiple levels for the best 
results[3].  Other studies emphasize the importance of demographic influences on vaccine 
uptake, likewise using data from survey[5, 18, 19].  A  study in particular out of Tanzania 
challenged the notion of “homogenous socioeconomic status” in rural, low-income African 
villages.  Findings detailed that care-seeking behavior is still varied among this level, and 
successful interventions need to take multiple measures of poverty and well-being into 
account[20]. 
2.4 “AFRICANIZATION” OF THE DEMAND FOR HEALTH 
Health economist Michael Grossman changed the notion that health was only determined by 
inputs related directly to medical care.  His research emphasizes that “good health” is actually a 
demand of consumers and is determined by a consumer’s specific demand is determined by 
economic, social, and environmental constructs[21].  While a p overty level can be set at one 
dollar a day or by a single national standard, it is difficult to capture the true demand for health 
on such a superficial level.  More recent research applies his method of calculating this demand 
to the health status in Sub-Saharan Africa[22].  Researchers used the same model, utilizing the 
ration of health expenditure to GDP and food availability per capita to determine the economic 
construct, literacy rates and alcohol consumption to determine the social construct, and 
urbanization rates and carbon dioxide emissions per capita to determine the environment 
construct. 
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Health inequalities can be seen all over the world in both high-income and low-income 
countries.  However, research shows they are very different per level of income.  For example, 
the inequalities that exist in many Sub-Saharan African (SSA) nations are magnified by different 
social and economic differences than of those in the western world.  W ith the creation of the 
Commission on the Social Determinants of Health (CSDH), established by the WHO, an 
international interest on identifying the social determinants of health had been spurred.  Much of 
the focus of these studies still emphasize these determinants within the realm of the western 
world, not taking into account the differences from an sub-Saharan African perspective.  In 2011, 
researchers out of the University of Cape Town highlighted the need for the “Africanization” of 
the social determinants of health in order for there to be progress in the overall health of African 
nations[23].  H ealth has to be determined within the realm of the individual country, if not 
broken down further into national regional disparities.  While low socio-economic status (SES) is 
a determinant of health, it is simply not enough to use this as a reason for poor health in sub-
Saharan Africa when roughly 50% of the population lives below the poverty line [24].  
Dr. Peter Ndumbe has done vast research on t he subject of immunization programs in 
Africa.  Currently Dean of the Faculty of Medicine and Biomedical Sciences at the University of 
Yaoundé in Cameroon, he is also a member of the Task Force on Immunization in the African 
Region of the World Health Organization.  Due to his years of expertise in the field, Dr. Ndumbe 
is regarded as an expert in regards to immunization practices in Africa.  According to Dr. 
Ndumbe, there are four main reasons as to why vaccines do not reach the populations in Africa 
that need them most: 
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• Management: training of personnel, supervision of the program, scheduling of 
vaccine administration 
• Finance: lack of financial resources, purchasing power of citizens 
• Logistics: weak supply chain, lack of storage, shipment delays 
• Social mobilization: community involvement, buy-in, acceptance  
Across all four reasons exists barriers that need to be overcome in order to achieve better 
access[4].  These constructs parallel with much of the McLeroy, et al, proposal of social 
ecological model of health promotion[25].  By understanding immunization barriers at all levels 
in the system as opposed to separating the upper levels (policy makers) from the societal levels 
of community and the individual allows researchers to gain a better overall perspective on ways 
to fix problems and implement successful interventions.  Far too often the physical cold chain 
supply and the supply of vaccines into the community are treated as separate issues; they should 
both be considered simultaneously when planning an immunization intervention. 
2.5 NIGER 
2.5.1 Country Overview 
Niger is a landlocked nation in west Africa, surrounded by Nigeria and Benin to the south, 
Burkina Faso and Mali to the west, Algeria and Libya to the north, and Chad to the east.  80% of 
the country is covered by the unforgiving Sahara Desert, leaving only a small portion of the land 
suitable for farming and livestock.  This remaining 20% mostly falls within the Sahel region of 
Africa, a region marked by environmental damage and a struggling economy.  There is a very 
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narrow strip of land just below the Sahel called the Sudanian vegetation zone, which offers the 
most suitable farming land in the country.  Farming in Niger is mostly subsistence farming, 
which is frequently disrupted by droughts and famine.  In addition, the soil quality is poor and 
overgrazed, and when rainfall does occur, it usually floods the region[26].  Pastoralist 
communities also suffer from the effects of droughts and sub sequential cyclical flooding[27].  
Numerous famines since the 1970s have deemed international attention, the most recent being in 
2010.  During this time, it was estimated that 12 million of the 15.2 million population faced 
severe food shortages[28]. 
Niger has few areas of natural resources being mined.  Uranium, gold and coal are the 
main three natural resource exports.  Niger is one of the world’s leading uranium producers, and 
uranium mining has existed in Niger for over 40 years operated by private firms[29].  The first 
national gold mine was opened in 2004 i n southwest Niger and is expected to bring in 
sustainable revenue for the country, as the government has a 20% share in this mine.  Potential 
oil fields are being researched in western Niger.  However, these areas can do little to make up 
for the unforgiving landscape of Niger, where most people are farmers. 
Niger has the highest birth rate (50.06/1,000) and the second highest infant mortality rate 
(109.98/1,000) in the world[30].  With a population of just over 15 million (2010 estimates) and 
a population growth rate of 3.63%, Niger represents a country with a critical need to immediately 
address maternal and child health.  Culturally, Niger is a pronatalist nation, with many couples 
continuously desiring more children[28].  The number of children born per Nigerien is 7.52; a 
survey conducted in 2006 of married women and men reported that they wanted an average of 
8.8 and 12.6 children, respectively.  
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Consistently one of the poorest nations in the world, the per capita income of Niger is 
$370 USD with 59.5% of the population living below the estimated national poverty line[30, 31].  
This is higher than the average of sub-Saharan Africa, which is about 50%.  In addition, roughly 
$20 USD is the average expenditure per household on he althcare services[32].  P overty is 
highest in the rural areas along the southern border where a majority of the population lives.  
Education is poor and struggling.  Primary school enrollment is 63%, and adult literacy rates are 
among the lowest in the world at 29%[31]. 
2.5.2 Regional Overview 
Niger is composed of eight regions: Agadez, Niamey, Diffa, Dosso, Tahoua, Tillabéri, Maradi, 
and Zinder.  Diffa and Agadez are the most remote of the regions.  Niamey has the densest 
population and is the capital of the country.  Maradi and Zinder have a spread of dense and rural 
districts, and Tillabéri, Tahoua, and Dosso have similar patterns with a smaller population 
(Figure 1 and Table 1).   
 
Table 1. Population per Region Stratified by Males and Females 
 
Agadez Diffa Dosso Maradi Tillabéri Tahoua Zinder Niamey 
Male 245,881 242,672 997,187 1,492,324 1,258,651 1,316,673 1,430,284 610,893 
Female 241,432 230,891 1,019,503 1,528,845 1,241,803 1,341,426 1,394,184 611,173 
Total 487,313 473,563 2,016,690 3,021,169 2,500,454 2,658,099 2,824,468 1,222,066 
Data obtained from the 2006 Demographic and Health Survey in Niger 
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From: www.infrastructureafrica.com; April 2012 
Figure 1. Density of Population of Niger by Region 
The population of Niger was estimated to be just over 15 million in 2010.  When comparing 
Table 1 with Figure 1 at the beginning of this section, the population density varies greatly per 
region.  The most populated regions are along the southern border of the country, while the least 
populated region is the largest (Agadez) in the north. 
The majority of the population falls below the Sahel in the Sudanian vegetation zone.  
However, as discussed previously, this area of land is prone to drought and famine.  It is 
important to note that these regions are still considered rural, although denser.  Figure 2 outlines 
the spread of poverty in Niger.   
Per region, the percent of people living below the national poverty line stratifies as 
follows according to Niger’s National Institute of Statistics: Agadez (16%), Diffa (18%), Niamey 
(28%), Zinder (54%), Tahoua (58%), Dosso (67%), Tillabéri (72%), Maradi (73%)[33].  
Although the numbers do not  quite match the percentages of the map, the pattern is still the 
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same.  T he most remote regions of Agadez and Diffa are characterized as “wealthier” while 
Tillabéri and Maradi rank as two of the “poorest.”  It is difficult to tell from Figure 2 Niamey’s 
true poverty incidence; it is the capital but is located in the poorest section of the country. 
 
From: www.infrastructureafrica.com; April 2012 
Figure 2. Poverty Distribution in Niger 
 
 Niger’s workforce is divided mainly into three sectors: agriculture, excavation (mining), 
and service.  Figure 3 from Infrastructure Africa highlights the locations of the agriculture and 
mining activities in Niger.  Agadez is home to a massive uranium excavation project.  Diffa has 
been sited as a location with potential to have oil, and the southwest region of the country has 
been known to have large deposits of gold.  In conjunction with the Sudanian vegetation region, 
most of the farming lies along the southern border of the country.  However, as noted earlier, this 
region has a precarious envorinment that is known for severe famines. 
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From www.infrastructureafrica.com; April 2012 
Figure 3. Natural Resources in Niger 
 
 By looking at the numerous variations of Niger at the regional level, it is evident that 
poverty ranges across all regions.  Therefore, by treating poverty as a uniform state when 
designing interventions such as immunization campaigns would not be the best solution to 
increasing vaccination coverage. 
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3.0  METHODS 
This study will analyze measures of vaccine availability, vaccine coverage, and incidence of 
poverty in Niger at the regional level.  It will specifically study the yellow fever vaccine.  This 
vaccine was chosen for several reasons.  First, it is a single dose vaccine, meaning a child is 
considered to have completed the recommended yellow fever uptake after one dose; it is more 
straightforward to compare the vaccine availability with vaccine coverage without factoring in 
multiple dose schedules and missed opportunities.  O ther single dose vaccines include Bacille 
Calmette-Guérin (BCG) and measles.  BCG is a vaccine that is administered at birth, and 
therefore would be highly correlated with access to the option to give birth in a health facility.  
While this reflects socio-demographics, it also weakens the ability to analyze other health 
seeking behaviors.  The measles vaccine is often supplemented by campaigns, and therefore it 
would be expected to have coverage not fully reflecting the availability of the vaccine through 
the national EPI.  Therefore, of the single dose vaccines administered, the yellow fever vaccine 
represents a v accine that is representative of the need to actively seek out vaccination (as 
opposed to being located by campaigns) and is not confounded with access to birthing facilities. 
 Three data sources are analyzed in order to examine the relation between socioeconomic 
status and vaccine availability.  The first is a computational model developed by the University 
of Pittsburgh that will determine the vaccine availability of the yellow fever vaccine in Niger.  
The second is a health survey administered in Niger to determine the vaccine coverage rates of 
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the yellow fever vaccine.  The final data source is a measure of poverty composed of measures of 
education, health and living standards that allow a more in depth analysis of the socioeconomic 
status in a seemingly uniformly low-income country. 
3.1 VACCINE AVAILABILITY 
The Highly Extensible Resource for Modeling Supply Chains (HERMES) is a discrete event 
simulation model developed by the Vaccine Modeling Initiative at the University of Pittsburgh.  
HERMES includes information regarding vaccine vial size, storage capacity, transportation 
capacity and routes, and the number and location of all clinics in the country of Niger (Figure 4.) 
 
From: https://www.vaccinemodeling.org/index.php/hermes-vision-secret; April 2012 
Figure 4. How HERMES Works 
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HERMES is populated with data from the 2008 Niger Cold Chain Inventory and was 
further detailed with data from a team visit in 2009.  Examples of subjects previously explored 
include vaccine vial size, vaccine introduction, and vaccine ordering policy [34-39].  The model 
in Niger represents the flow of vaccines from the central storage facility in Niamey throughout 
the country, eventually reaching integrated health centers (immunization clinics) and therefore 
being administered to the population.  One run of the model represents one year.  The size of 
orders is determined by demand at the clinic locations.  Figure 5 illustrates how the supply chain 
works in Niger. 
 
 
Map from: www.un.org/depts/Cartographic/map/profile/niger.pdf; March 2012 
Figure 5. Niger’s Vaccine Cold Chain 
  
Each day, virtual patients arrive to the clinics and vaccines are administered based on 
census data gathered in Niger.  The ability of patients to be vaccinated at the clinic level is 
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measured by vaccine availability.  Vaccine availability is the proportion of patients arriving to 
the clinic to be vaccinated for whom vaccine is available.  It is represented by the following 
equation: 
 
Vaccine Availaibility = Number of vaccine doses available at the clinic / number of 
patients arriving at the clinic to be vaccinated 
 
 In addition to studying vaccine availability, this study will analyze what impacts vaccine 
availability overall, such as: 
• Cold storage utilization: the proportion of used space in all refrigerators, freezers, and 
cold rooms thoughout the supply chain to the amount of available space, represent by: 
• Frequency of shipments: the number of trips taken from higher levels in the supply chain 
to lower levels in the supply chain to restock vaccine over the total possible number of 
trips that could be taken between levels per year 
The vaccine availability reported for the yellow fever vaccine is the result of the average of ten 
runs. 
3.1.1 Baseline Data from HERMES 
Figure 6 represents the vaccine availability across the different regions in Niger.  Tillabéri had 
the highest availability at 85%, while Agadez offered the lowest vaccine availability at 21%.  
Maradi, Tahoua and Zinder had relatively similar availabilities, all falling between 84% and 
85%.  Diffa, Dosso, and Niamey represented another tier of availabilities, with Diffa and Dosso 
having an availability of 53% and Niamey having an availability of 57%.  T he average 
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availability across the country would most likely not be an accurate representation of what is 
actually offered from the perspective of the regional level. 
 
Figure 6. Yellow Fever Vaccine Availability 
 
 With such varying numbers, understanding the interaction of additional measures helps to 
Other relevant outputs impacting vaccine availability include storage capacity and shipping 
frequency.  Table 2 represents the number of storage locations, the space offered totaled across 
all locations within the level, and the average utilization at each location. 
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Table 2. Number of Vaccine Storage Locations per Region in Niger 
Regions 
Number 
of 
Regional 
Stores 
Total 
Store 
Space 
(L) 
Average 
Storage 
Utilization 
Number 
of District 
Stores 
Total 
Store 
Space 
(L) 
Average 
Storage 
Utilization 
Number of 
Integrated 
Health Centers 
(IHCs) 
Total 
Store 
Space 
(L) 
Average 
Storage 
Utilization 
Agadez 1 110 100% 4 1,367 23% 44 2,010 16% 
Diffa 1 301 100% 3 771 41% 35 1,298 37% 
Dosso 1 822 100% 5 1,015 68% 86 3,357 38% 
Maradi 1 12,355b 21% 7 1,166 78% 84 3,812 35% 
Tillabéri 0a N/A N/A 6 1,137 73% 120 4,319 40% 
Tahoua 1 16,169b 14% 8 1,178 77% 110 3,822 42% 
Zinder 1 12,277b 19% 6 1,745 63% 117 4,445 44% 
Niamey 1 369 47% 3 632 59% 48 1,916 40% 
a Regional level removed from supply chain; central store serves District Stores directly 
b location has a cold room 
 
The amount of storage space at each level within the regions is a l arge factor in the 
vaccine availability by the end of the supply chain.  In Agadez, for example, storage at the 
regional level is utilized to the maximum capacity, creating a bottleneck as soon as the vaccines 
enter the region.  110 L of total storage space is equal to a single refrigerator.  The analysis of 
transport utilization will further explain how detrimental this lack of space is to the overall 
availability.  The final level within Agadez (Integrated Health Centers) only utilizes an average 
of 16% of available storage space; the available space totals to almost 20 times the available 
space at the regional level. 
The ability for certain locations to have a cold room for storage at the regional stores can 
be viewed as both a benefit and a waste of space.  The vaccine availability for the regions with 
the cold rooms is much greater than the supply ratios of those without, which shows a connection 
between space and availability.  However, the utilization rates of the storage at the regional level 
is quite low (14-21%), indicating a lot of empty space.  While Niamey does not seem to be 
utilizing a lot of storage space and therefore should have higher vaccine availability, this is 
explained in shipping frequency. 
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Tillabéri does not have a storage facility at the regional level.  Therefore, the central store 
delivers directly to the six district stores, eliminating the potential bottleneck that could occur.  In 
addition, Tillabéri has a very large amount of storage space at both the district level and the IHC 
level. 
Niger’s vaccine transportation system from the central store to the district stores works in 
two ways in this model (Figure 7.)  There are two shipping loops that run from the central store 
to three regional stores.  Each loop has one cold truck stocked to deliver vaccines to all three 
locations and follows one of the two main highways in Niger.  Loop A delivers to Maradi, 
Zinder and Diffa, while Loop B delivers to Dosso, Tahoua and Agadez.  The loops use cold 
trucks to carry the vaccines, and the cold trucks do not have a utilization rate higher than 50% on 
either route. 
 
 
Map outline from: http://www.worldatlas.com/webimage/countrys/africa/outline/neout.htm; March 2012 
Figure 7. Vaccine Shipping Loops in Niger 
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The remaining two regions (Niamey and Tillabéri) operate in a different manner.  The 
central store is located in Niamey, so HERMES allows Niamey regional store could be stocked 
very frequently, as is practiced in Niger.  The means of transportation is a 4x4 truck.  Tillabéri 
does not have a regional store; therefore, vaccine is collected by districts directly from the 
district stores. 
Aside from Tillabéri and Niamey, each Regional level store can have vaccine delivered 
from Central store every three months as long as there is vaccine available at the central store to 
be moved (Table 3.)  The Niamey regional store is able to restock once a month.  Regional stores 
can deliver vaccine to the district stores once a month as long as there is vaccine available at the 
regional level.  (Tillabéri districts can have vaccine delivered from central once a month as well.)  
This leg of the vaccine transportation system uses 4x4 trucks.  IHC’s can collect from district 
stores once a week as long as there is vaccine available.  This leg uses motorbikes with vaccine 
carriers attached in order to reach all IHCs, including the remote ones. 
 
Table 3. Frequency of Shipments Between Levels per Year 
 
Every region used the maximum amount of shipments from central as possible.  T he 
region to district shipments is where there are differences in the average amount of trips per year.  
Those locations with more storage at the regional level (Maradi, Tahoua, Zinder) all are still 
about to ship as many times as possible per year on average since there is more room to store.  
Regions that lack a lot of cold storage at the regional level (for example, Agadez) have fewer 
 Agadez Diffa Dosso Maradi Tillabéri Tahoua Zinder Niamey 
Central to Region 4 4 4 4 N/A 4 4 12 
Region to District 4 9 5 12 12 12 12 8 
District to IHCs 4 11 10 22 17 17 18 11 
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shipments, for there is no vaccine to transport throughout the system once the regional level runs 
out.  Therefore, more shipments in HERMES lead to higher vaccine availability. 
3.2 VACCINE COVERAGE 
The Demographic and Health Survey (DHS) is an in-country survey conducted by Monitoring 
and Evaluation to Assess and Use Results Demographic and Health Survey (MEASURE DHS), a 
project funded by USAID and implemented by ICF International[40].  The survey is designed to 
give a broad view of the demographic structure of the country, aiming to create monitoring and 
evaluate indicators of population, health, and nutrition.  The survey is typically administered 
every five years in order to give researchers the ability to study trends. 
The last completed survey in Niger was in 2006.  7,660 households completed the survey, 
with inputs from 9,223 women and 3,549 men.  The ages ranged from 15-59.  The topics covered 
include household structure, immunization uptake for children, and employment, to name a few.  
The time frame for the 2006 DHS was from January through May.  There is currently a survey 
being conducted now and the DHS 2012 will be released next year. 
 Data utilized for this study will be in regards to the yellow fever vaccination uptake.  The 
reported coverage rates reflect mothers being questioned in regards to what vaccines their 
children had received.  This was determined by both evidence of vaccination cards and the 
mothers memory regarding immunization sessions.  Overall, majority of the questions regarding 
immunization were answered by word of mouth as opposed to consulting immunization cards. 
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3.2.1 Data Extracted from the DHS 
The DHS reports vaccination coverage rate of all EPI vaccines singularly (Table 4.)  It also 
produces the rates for a fully immunized child (FIC), which is generally much lower than 
individual uptake. 
 
Table 4. Vaccine Coverage per Region in Niger 
 
 
BCG DTP 3 Measles OPV 4 Yellow Fever 
Fully Immunized 
Child 
Agadez 82% 62% 69% 62% 59% 50% 
Diffa 73% 40% 55% 50% 39% 24% 
Dosso 71% 47% 58% 63% 44% 27% 
Maradi 59% 31% 41% 54% 34% 21% 
Tillabéri 65% 46% 54% 66% 46% 35% 
Tahoua 71% 47% 50% 60% 36% 23% 
Zinder 41% 22% 26% 33% 17% 13% 
Niamey 94% 55% 78% 64% 66% 36% 
 
3.3 THE MULTIDIMENSIONAL POVERTY INDEX 
The socioeconomic status of Niger at the regional level was derived from the findings of the 
Multidimensional Poverty Index (MPI.)  Developed by the Oxford Poverty and Human 
Development Initiative and the United Nations Development Program in 2010, the MPI adopts a 
deeper definition of poverty[41].  T he MPI captures a broader picture of poverty than the 
traditional income-based methods, for it factors in education, health, and standard of living to 
determine the level of poverty. 
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Across these three categories, there are ten indicators: 
• Education: years of schooling, school attendance 
• Health: child mortality, nutrition 
• Standard of Living: cooking fuel, sanitation, water, electricity, floor, asset ownership 
 
If an individual is lacks at least one third of the indicators, they are identified as poor.  The 
indicators are calculated from in-country surveys, such as the Demographic and Health survey.  
The Niger MPI specifically utilized the 2006 DHS, the same survey this study uses to determine 
vaccine coverage rates.  In comparison with the percentage living below the National Poverty 
Line in Niger (59.5%), the MPI offers a more holistic approach to understanding the depth of 
poverty in a country.  The benefits of using this measure in this setting is that in a country such 
as Niger, where a majority of the country is classified as living in economic poverty, the MPI 
offers additional insight into the influences to poverty.  The three categories factored into 
calculating the MPI are all associated with health behavior; therefore, it would be relevant to 
study a measure of poverty with direct relation to vaccination uptake. 
 
3.3.1 Data Extracted from the MPI 
According to the MPI, the head count ratio of poverty in Niger is 92.4% on average and varies 
by region, as seen in Table 5: 
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Table 5. Multidimensional Poverty at the Regional Level in Niger 
Region Percentage of Population 
Multidimensional 
Poverty Index 
(MPI = H x A) 
Incidence 
of Poverty 
(H) 
Average 
Intensity 
Across the 
Poor (A) 
Agadez 2.5% 0.47 77.4% 60.4% 
Diffa 2.7% 0.61 93.8% 65.0% 
Dosso 13.7% 0.659 96.1% 68.5% 
Maradi 20.4% 0.676 96.3% 70.2% 
Tillabéri 14.2% 0.698 97.1% 71.8% 
Tahoua 19.0% 0.676 95.7% 70.7% 
Zinder 20.2% 0.678 95.2% 71.2% 
Niamey 7.2% 0.275 52.8% 52.1% 
 
 For this study, the Incidence of poverty will be utilized to determine the poverty at each 
regional level in Niger.  The incidence represents the “head count” of those within the region that 
categorize as poor according to the standards set by the MPI. 
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4.0  RESULTS 
The data shows patterns of interest between all three indicators.  As the incidence of poverty 
increases across regions, vaccine availability increases as well.  T his general pattern indicates 
that the way the supply chain is currently operating might not be furthering socioeconomic 
disparities among regions. Figure 8 offers an overview of the relation of all three indicators, 
while subsequent sections analyze the relation of each indicator with one another. 
 
 
Figure 8. Incidence of Poverty, Vaccine Availability, and Vaccine Coverage 
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4.1 VACCINE AVAILABILITY AND SOCIOECONOMIC STATUS 
When the vaccine availability, as determined by HERMES, was compared with the incidence of 
poverty, as determined by the MPI, the results were quite interesting.  An overall trend, as shown 
in Figure 9, i s that the regions with higher levels of poverty also have a higher proportion of 
vaccine availability.  Agadez, a region with only 21% vaccine availability at the clinic level, is a 
region with a below average poverty incidence in Niger (poverty incidence of 77%.)  However, 
Zinder, the region with the highest proportion of vaccine availability, is also one of the poorest 
regions in the country. 
 
 
Figure 9. Incidence of Poverty and Yellow Fever Vaccine Availability 
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4.2 VACCINE AVAILABILITY AND VACCINE COVERAGE 
When comparing vaccine availability, as determined by HERMES, with the vaccine coverage 
rates for yellow fever, as determined by the DHS conducted in Niger, the results show varying 
pattern (Figure 10.)  While Agadez has a very low vaccine availability (21%) the coverage rate is 
much higher (59%.)  In addition, the regions with the highest availability rate also have the 
lowest coverage rates (Zinder, Tahoua, Tillabéri.)  In two instances, the vaccine coverage rate is 
actually higher than the vaccine availability rate, potentially showing that people are being 
vaccinated at other locations.  The vaccine is technically getting to the clinics for immunizations 
to be administered, but this shows that there is disconnect between the vaccine arriving at the 
population arriving. 
 
 
Figure 10. Yellow Fever Vaccine Availability and Vaccine Coverage 
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4.3 VACCINE COVERAGE AND SOCIOECONOMIC STATUS 
As the incidence of poverty increases across the regions in the country, the yellow fever vaccine 
coverage rates initially decreases.  It is interesting to note that after coverage rates initially drop 
as expected, they become higher for some reason in regions with virtually the same incidence of 
poverty.  Zinder represents the region with the lowest vaccine coverage rates (17%) and one of 
the highest rates of poverty, and yet regions with the same level of poverty (Tahoua, Dosso, 
Maradi, Tillabéri) show higher rates of coverage.  Figure 11 outlines this trend. 
 
 
Figure 11. Incidence of Poverty and Yellow Fever Vaccine Coverage 
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5.0  DISCUSSION 
Analysis of the indicators of vaccine availability, vaccine coverage, and the incidence of poverty 
outline interesting trends worth discussing further.  Overall, it appears that vaccine availability is 
not hindering the vaccine coverage, for in the majority of the regions vaccine availability 
remains higher than vaccine coverage.  There are two regions for which the vaccine coverage is 
higher than availability, and further research could better explain the initial thought process 
behind why this occurs. 
5.1 HIGHER AVAILABILITY THAN COVERAGE 
Higher availability than coverage would be somewhat expected scenario in a low-income 
country such as Niger.  Essentially, this means that the government is getting the vaccine to the 
clinics, and the problem lies in getting the patients to the clinics.  This occurred in Maradi, 
Tillabéri, Tahoua, Zinder, Dosso and Diffa.  There are two tiers of vaccine availability outlined 
between these six regions.  M aradi, Tillabéri, Tahoua and Zinder represent areas of high 
availability, mostly due to having more cold space available and more frequent trips to restock 
vaccines.  However, these are also four of the poorest regions of Niger.  In all of these regions, 
over 90% of the population in all of these regions lives in poverty.  As discussed earlier, the 
demand for health is quite different at this level.  Preventative medicine is not generally a 
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priority in an area suffering from malnutrition and famine.  From the perspective of the supply 
chain, however, it is working to get the vaccine where it is needed.  Outreach campaigns for the 
yellow fever vaccine would most likely be beneficial in Niger, as yellow fever is a major factor 
of the burden of vaccine preventable diseases. 
 
Dosso and Diffa have somewhat lower vaccine availability than the other four regions; 
however, they are still among the poorest regions in the country.  Perhaps these two regions 
would be a point to study additional ways the supply chain could be impacting the coverage 
rates.  There is less than a 15% difference between coverage and vaccine availability.  Data such 
as this would be helpful if planning an awareness campaign with the intention to produce social 
mobilization to have more people seek vaccines; could the potential new demand overpower the 
current supply system?  As yellow fever is not traditionally a vaccine used in outreach 
campaigns, it would still be administered from a clinic and would need the proper supply.  
However, for the most part this data is showing that in each region, there is a higher availability 
than coverage, and the supply chain is not hindering the availability of vaccines to regions of 
lower socioeconomic status. 
5.2 HIGHER COVERAGE THAN AVAILABILITY 
Agadez and Niamey both showed higher vaccine coverage than availability.  The main question 
is how are these regions getting higher coverage than vaccines available?  An option is to look at 
the pattern of outreach campaigns.  Numerous outside organizations run supplementary 
immunization programs in sub-Saharan Africa.  Unfortunately, not all of these programs keep 
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track of the population vaccinated. In addition, the DHS survey takes information from both 
government issued vaccination cards and the memory of the mother.  Therefore, a mother could 
be reporting an undocumented immunization campaign.  However, as stated before, yellow fever 
is not typically a vaccine that is used in such activities, although recent reports indicate that it 
would be both safe to administer with and beneficial to include in a measles campaign[42]. 
Both of these regions are wealthier in comparison to all other regions.  Agadez has a 
poverty incidence of 77% and Niamey has one of 53%.  In the context of Niger, all other regions 
have incidences of poverty over 90%.  Another pattern to note is the location of mining activities 
within the country.  Uranium mines are located in Agadez.  The AREVA group, a French-owned 
company, has been operating uranium mines in Agadez for close to 50 years now[43].  There are 
two mines currently operating with construction of a third to begin this year.  AREVA also owns 
and operate two hospitals in the region with the intent to provide free healthcare to employees, 
their families and the surrounding community.  This is a probable site of immunizations that are 
taking place that would be unaccounted for by the government.  A REVA has been known to 
provide funding to hospitals throughout Niger, most recently the Niamey National Hospital. 
Private companies, such as AREVA, have long been a controversial topic in developing 
nations.  In recent years, groups such as the Global Business Corporation have worked to turn 
multi-national corporations into disease-fighting superpowers.  These companies now aim to 
make investments into the healthcare of the community they employ in order to create a more 
sustainable relationship[44].  However, it is difficult for countries in dire economic problems to 
turn away any kind of help.  The problem is that a lot of these companies operate under 
unhealthy conditions.  In the past decade, AREVA specifically has been the target of Greenpeace 
for unsafe conditions, radioactive waste, and not investing enough in the community[45].  
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AREVA has since worked to clean the radioactive hotspots and invest in the community through 
schools and hospitals, but the company is still under scrutiny on mining practices.  Regulations 
and pay scales are quite different between countries, hence why local manpower is convenient 
for international businesses. 
Mines are also in close proximity to Niamey, although not as isolated to just that region 
as the uranium mines are to Agadez.  Much of the gold mining activities in Niger take place just 
outside of Niamey, technically in Tillabéri.  The region of Niamey is inside of the region of 
Tillabéri, located along the Niger River where the mines are located.  Information on the gold 
mining activities is limited; however SEMAFO, Inc owns and operates the gold mines outside of 
Niamey.  T he SEMAFO website has a section outlining corporate responsibility to the 
community, including financing hospitals and doctors for the mining operations[46].  S pecific 
examples showing corporate responsibility to Niger are not directly outlined. 
Niamey has recently seen an enormous increase in the size of the population over the past 
few years, most likely due to the increase of mining in the area.  Residents of Niamey could be 
migrants vaccinated in other countries and therefore not utilizing the services offered by the EPI.  
Again, practices of tracking vaccination are very different among countries. 
5.3 LIMITATIONS 
Although models are robust representations of actual events, they simply cannot capture every 
single detail that could impact the supply chain.  It should be understood that these 
representations should be used to guide the decision making process and not be the sole source of 
evidence.  Further, the parameters of the country change every year.  New surveys will be 
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administered and various determinants can change, hence why it is important to utilize as much 
up-to-date data as possible. 
5.4 IMPLICATIONS FOR PRACTICE 
Knowing what regions are producing high vaccine availability is vital to understanding the best 
method for running the supply chain.  If it is a matter of space, transport routes or frequency of 
shipments, these are adjustments that can be made to maximize the benefits of the supply system.  
While each region differs, a general framework to apply would be that there is a need for cold 
space much like Zinder, Tahoua and Maradi currently have.  For example, giving Dosso 
additional cold space might help to increase vaccine coverage over time.  In addition, it 
highlights areas of low vaccine coverage despite high vaccine availability.  This might be 
emphasizing wasted resources by the government. 
This type of study also sheds light on other sources of vaccination services.  In Agadez 
and Niamey, people are receiving vaccines elsewhere.  Although this study is limited in telling 
the government where these people are being vaccinated, it dictates that there is some kind of 
difference between regions that cause people to be vaccinated even when the services is limited.  
Agadez, a region with extremely low availability and fairly high coverage in comparison to other 
regions, is a perfect example of people seeking healthcare beyond the national vaccine system. 
Finally, utilizing a social ecological framework stresses the importance of stakeholders 
understanding how all of these factors are entwined with one another.  The need for 
immunization programs to be designed with this theory in mind creates natural checkpoints to 
examine, such as if the availability is really meeting the demand. 
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5.5 FURTHER RESEARCH 
The results of this study are not finite.  Rather, numerous additional research opportunities could 
be complementary to these findings.  To begin with, further analysis at the district level (the one 
directly below the regional level) would yield more detailed results.  Patterns would emerge that 
are distinct to each region as a whole.  A dditional stratification by other demographic 
characteristics at this level, such as ethnic background, could help decipher cultural acceptance 
of vaccines in relation to the available supply. 
Further research into the private facilities, such as those owned by the mining industry, is 
necessary to understand this effect across the country.  Right now, it is only determined that this 
could be impacting the coverage rates in one region.  However, as mining is further pursued 
across the country in both Diffa and Dosso, it would be of assistance for the Ministry of Health 
to have an idea as to how mining impacts healthcare. 
Finally, an analysis of the various outreach campaigns that are in the country would help 
to understand why coverage would be higher than availability.  Again, it would be very 
beneficial for the government and stakeholders in the vaccine supply chain to know additional 
venues of vaccination.  Therefore, efforts in Niger would be better organized.  In a low income 
country, utilizing every vaccine resource from the government clinics to the foreign-run outreach 
campaigns help to create a stronger immunization program.  In addition, a single method of 
tracking vaccination efforts by different campaigns would help to understand the reach of such 
efforts. 
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6.0  CONCLUSION 
The purpose of this study was to determine if discrepancies in the supply chain reflect regions of 
lower socioeconomic status in Niger.  If so, what could be potential causes of such 
discrepancies?  Findings showed that the areas of highest vaccine supply availability had some of 
the lowest rates of vaccine coverage.  This would reflect a problem of getting the patients to the 
vaccine; the supply chain is functioning in respect to getting vaccine to the clinics for 
immunization sessions.  In addition, these areas also had a large amount of cold space at the 
regional level, which is associated with higher vaccine availability.  This helps highlight points 
of intervention to the government in an ecological perspective, for adequate vaccine availability 
does not mean high vaccine coverage. 
Another interesting pattern was areas that had higher vaccine coverage than vaccine 
availability, meaning patients were potentially being vaccinated outside of the clinics set up by 
the government.  This could be reflective of two patterns of immunization: outreach campaigns 
from outside organizations are offering immunization services to the people of Niger, or else 
hospitals and clinics funded and run by outside governments are offering immunization services.  
Both of these options are very feasible, as Niger is a poverty-stricken country that receives a lot 
of humanitarian aid.  In addition, mining is a huge industry in the region that is owned and 
operated by foreign companies.  In response to harsh criticism on not giving enough back to the 
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community, mining companies often offer free health services from private facilities.  In this 
sense, the government might be missing vaccination sessions to quantify. 
Such a study offers assistance to key stakeholders planning immunization services in 
Niger.  By understanding areas of high coverage and low coverage, factors that influence this, 
and ways to get vaccines to communities that need it most, the system can be strengthened to 
reach as many Nigeriens as possible.  This study is significant in understanding the outcomes of 
the two parts of the vaccine supply chain in Niger (vaccine availability at the clinic and vaccine 
uptake by the population) and can help guide those in the field of public health to intervene in the 
system at places that will yield the most impact per region. 
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